Squarepoint Capital is a global quantitative investment management firm that focuses on developing sophisticated, systematic, and data-driven trading strategies. They leverage advanced mathematical models and statistical methods to achieve high-quality, uncorrelated returns across diverse asset classes like equities, futures, options, and forex.
50% of their portfolio is in Healthcare. They made 2 investments in the last 12 months. Average disclosed round size is $147.2M (across 8 rounds with reported amounts).
Portfolio
8
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 PolyAI | Series D | $86M | Dec 2025 |
 CurbWaste | Series B | $28M | Oct 2025 |
 Harbinger Motors | Series A | $60M | Sep 2023 |
| WWefox | Series D | $110M | May 2023 |
| BBioVentrix, Inc. | Series A | $48.5M | Apr 2023 |
 Cera Care | Growth | $310M | Aug 2022 |
 Cera | Growth | $320M | Aug 2022 |
 Enable Injections, Inc. | Series C | $215M | Jan 2022 |
Top Co-Investors
Jane Street Capital2 shared
Schroders Capital2 shared
Yabeo2 shared
Guinness Ventures2 shared
Oltre Impact2 shared
8090 Partners2 shared
Flourish Ventures1 shared
TTV Capital1 shared
B Capital1 shared
Cox Enterprises1 shared
Magnetar1 shared
GCM Grosvenor1 shared
Ohio Innovation Fund1 shared
Andera Partners1 shared
Cormorant Asset Management1 shared
Khosla Ventures1 shared
Redpoint Ventures1 shared
Georgian Partners1 shared
Hedosophia1 shared
NVentures1 shared
Last updated: 16 April 2026